Long-term Follow-up After Stroke (The LAST-long Trial)

Launched by NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY · Feb 27, 2019

Keywords

ClinConnect Summary

The LAST-long Trial is a clinical study aimed at helping people who have had a stroke. Even though treatments for strokes have improved, many stroke survivors face challenges like difficulties with movement, thinking, feeling depressed, or being overly tired, which can affect their recovery and quality of life. This trial is testing a personalized program designed to help prevent these problems and support better long-term outcomes for stroke survivors.

To join the study, participants must be living in certain areas of Norway and have experienced their first or a recurring stroke. They should also have some level of functional or cognitive difficulties, as determined by specific tests. Participants will receive a tailored intervention aimed at improving their recovery. It's important that they can understand Norwegian and are willing to participate fully. The trial aims to provide valuable insights into how to improve the lives of those recovering from a stroke.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of first ever or recurrent stroke (ischemic stroke or hemorrhage)
• • mRS \< 5
• • Living in Trondheim, Skedsmo or Lørenskog municipality
• • Less than 10 points on Short Physical Performance Battery (SPPB) OR less than 26 points on Montreal Cognitive Assessment (MoCA) OR more than 27 points on the 7 item version of the Fatigue Severity Scale (FSS-7) OR more than 7 points on the depression or anxiety items on Hospital Anxiety and Depression Scale (HADS) OR reduced hand function (i.e. fails on Motor Assessment Scale - Advanced arm- and hand function, item 3)
• • Able to understand Norwegian
• • Able and willing to sign informed consent.
• Exclusion Criteria:
• • Life expectancy \< 12 months
• • Other serious diseases, judged by the medical doctor to make it difficult to comply with the intervention (i.e. serious neurological diseases or drug abuse).